@robbo24, I think your insights are strong on this. With the SAR deal, there's a low capex requirement for production. If this is large enough to remove that, or at least make it minimal, there will be no impediment to drive it higher. This one I'm good with, compared with another in REE where I've had plenty to say.
- Forums
- ASX - By Stock
- NXM
- Ann: Trading Halt
Ann: Trading Halt, page-28
Featured News
Add NXM (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.4¢ |
Change
-0.003(5.26%) |
Mkt cap ! $26.26M |
Open | High | Low | Value | Volume |
5.5¢ | 5.5¢ | 5.2¢ | $31.63K | 578.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 62579 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 400242 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 62579 | 0.052 |
1 | 300000 | 0.051 |
2 | 193284 | 0.050 |
1 | 450000 | 0.047 |
2 | 1500000 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 400242 | 2 |
0.058 | 43180 | 1 |
0.059 | 200000 | 1 |
0.062 | 200000 | 1 |
0.064 | 90000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NXM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online